vimarsana.com

Results from ongoing testing and monitoring of COVID-19 variants shows the rapid microfluidic test detects Omicron at a comparable sensitivity to other variants LONDON, Jan. 14, 2022 /PRNewswire/

Related Keywords

United Kingdom ,London ,City Of ,Nigel Lindner ,Colleen Mcmillen ,Exchange Commission ,Drug Administration ,Emergency Use Authorization ,Chief Innovation Officer ,Federal Food ,Cosmetic Act ,Lumiradx Platform ,Securities Litigation Reform Act ,Proxy Statement ,Lumiradx ,Analysis ,Onfirms ,Covid ,Ntigen ,Pest ,Detects ,Micron ,Variant ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.